UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Interferon pathway in SLE: one key to unlocking the mystery of the disease

Lupus science & medicine, 2019-01, Vol.6 (1), p.e000270

2019

Volltextzugriff (PDF)

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study

Frontiers in immunology, 2021, Vol.12, p.756941-756941

2021

Volltextzugriff (PDF)

C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205

Frontiers in immunology, 2021-01, Vol.11, p.622326-622326

2021

Volltextzugriff (PDF)

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

Arthritis research & therapy, 2024, Vol.26 (1), p.65-65, Article 65

2024

Volltextzugriff (PDF)

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness

Frontiers in immunology, 2019-09, Vol.10, p.2164-2164

2019

Volltextzugriff (PDF)

Sex differences in clinical presentation of systemic lupus erythematosus

Biology of sex differences, 2019-12, Vol.10 (1), p.60-60, Article 60

2019

Volltextzugriff (PDF)

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus

Arthritis research & therapy, 2023, Vol.25 (1), p.107-107, Article 107

2023

Volltextzugriff (PDF)

Novel risk genes for systemic lupus erythematosus predicted by random forest classification

Scientific reports, 2017-07, Vol.7 (1), p.6236-11, Article 6236

2017

Volltextzugriff (PDF)

O6 Epidemiology of moderate-to-severe SLE in Sweden

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A10-A11

2024

Volltextzugriff (PDF)

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A9-A10

2024

Volltextzugriff (PDF)

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A98-A98

2024

Volltextzugriff (PDF)

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

ACR open rheumatology, 2022-01, Vol.4 (1), p.27-39

2022

Volltextzugriff (PDF)

O10 Ischemic stroke subtypes in SLE-associations with a STAT4 risk genotype

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A13-A14

2024

Volltextzugriff (PDF)

Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity

Lupus science & medicine, 2021-01, Vol.8 (1), p.e000471

2021

Volltextzugriff (PDF)

P146 Low CD4+ T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A153-A153

2024

Volltextzugriff (PDF)

O16 pQTL analysis of ficolin-3 activity reveals a link between the lectin pathway of complement and hematological disease manifestations in systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A19-A19

2024

Volltextzugriff (PDF)

P13 Acquired ficolin-3 deficiency in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A51-A52

2024

Volltextzugriff (PDF)

P145 Circulating interferon-α levels are elevated during pregnancy in women with SLE who deliver infants that are small for gestational age, preterm and/or have low birth weight

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A152-A153

2024

Volltextzugriff (PDF)

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus

Lupus science & medicine, 2023, Vol.10 (2), p.e000926

2023

Volltextzugriff (PDF)

Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease

Lupus science & medicine, 2022, Vol.9 (1), p.e000752

2022

Volltextzugriff (PDF)

Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality-a national cohort study

Rheumatology (Oxford, England), 2024-04, Vol.63 (4), p.1104-1112

2024

Volltextzugriff (PDF)

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.736

2018

Volltextzugriff (PDF)

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1607

2017

Volltextzugriff (PDF)

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Annals of the rheumatic diseases, 2020-03, Vol.79 (3), p.363

2020

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Medicin Och Hälsovetenskap
(49)
Life Sciences & Biomedicine
(46)
Humans
(33)
Rheumatology
(33)
Reumatologi Och Inflammation
(31)
Rheumatology And Autoimmunity
(31)
Lupus
(29)
Systemic Lupus Erythematosus
(29)
Medical And Health Sciences
(28)
Clinical Medicine
(26)
Klinisk Medicin
(26)
Female
(25)
Male
(19)
Adult
(17)
Autoimmune Diseases
(17)
Middle Aged
(16)
Lupus Erythematosus, Systemic - Genetics
(15)
Risk Factors
(12)
Disease
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interferon pathway in SLE: one key to unlocking the mystery of the disease

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study

C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness

Sex differences in clinical presentation of systemic lupus erythematosus

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus

Novel risk genes for systemic lupus erythematosus predicted by random forest classification

O6 Epidemiology of moderate-to-severe SLE in Sweden

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

O10 Ischemic stroke subtypes in SLE-associations with a STAT4 risk genotype

Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity

P146 Low CD4+ T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

O16 pQTL analysis of ficolin-3 activity reveals a link between the lectin pathway of complement and hematological disease manifestations in systemic lupus erythematosus

P13 Acquired ficolin-3 deficiency in patients with systemic lupus erythematosus

P145 Circulating interferon-α levels are elevated during pregnancy in women with SLE who deliver infants that are small for gestational age, preterm and/or have low birth weight

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus

Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease

Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality-a national cohort study

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Suchergebnisse filtern